Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 423

1.

Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.

Mizuno S, Mikami Y, Kamada N, Handa T, Hayashi A, Sato T, Matsuoka K, Matano M, Ohta Y, Sugita A, Koganei K, Sahara R, Takazoe M, Hisamatsu T, Kanai T.

Inflamm Bowel Dis. 2014 Aug;20(8):1426-34. doi: 10.1097/MIB.0000000000000105.

PMID:
24991784
2.

[Roles of RORγt+ innate lymphoid cells in mucosal tissues of mouse and human].

Sawa S.

Nihon Rinsho Meneki Gakkai Kaishi. 2013;36(1):11-6. Review. Japanese.

3.

A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.

Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d'Hargues Y, Göppert N, Croxford AL, Waisman A, Tanriver Y, Diefenbach A.

Nature. 2013 Feb 14;494(7436):261-5. doi: 10.1038/nature11813. Epub 2013 Jan 16.

PMID:
23334414
4.

Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

Takayama T, Kamada N, Chinen H, Okamoto S, Kitazume MT, Chang J, Matuzaki Y, Suzuki S, Sugita A, Koganei K, Hisamatsu T, Kanai T, Hibi T.

Gastroenterology. 2010 Sep;139(3):882-92, 892.e1-3. doi: 10.1053/j.gastro.2010.05.040. Epub 2010 Jun 1.

PMID:
20638936
5.

Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria.

Hepworth MR, Monticelli LA, Fung TC, Ziegler CG, Grunberg S, Sinha R, Mantegazza AR, Ma HL, Crawford A, Angelosanto JM, Wherry EJ, Koni PA, Bushman FD, Elson CO, Eberl G, Artis D, Sonnenberg GF.

Nature. 2013 Jun 6;498(7452):113-7. doi: 10.1038/nature12240. Epub 2013 May 22.

6.

Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.

Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ, Bemelman WA, Mjösberg JM, Spits H.

Nat Immunol. 2013 Mar;14(3):221-9. doi: 10.1038/ni.2534. Epub 2013 Jan 20.

PMID:
23334791
7.

Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge.

Tumanov AV, Koroleva EP, Guo X, Wang Y, Kruglov A, Nedospasov S, Fu YX.

Cell Host Microbe. 2011 Jul 21;10(1):44-53. doi: 10.1016/j.chom.2011.06.002.

8.

Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.

Neves AR, Castelo-Branco MT, Figliuolo VR, Bernardazzi C, Buongusto F, Yoshimoto A, Nanini HF, Coutinho CM, Carneiro AJ, Coutinho-Silva R, de Souza HS.

Inflamm Bowel Dis. 2014 Mar;20(3):444-57. doi: 10.1097/01.MIB.0000441201.10454.06.

PMID:
24412990
9.

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.

Geremia A, Arancibia-Cárcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, Travis SP, Powrie F.

J Exp Med. 2011 Jun 6;208(6):1127-33. doi: 10.1084/jem.20101712. Epub 2011 May 16.

10.

Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.

Qiu J, Zhou L.

Semin Immunopathol. 2013 Nov;35(6):657-70. doi: 10.1007/s00281-013-0393-5. Epub 2013 Aug 23. Review.

11.

RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota.

Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Bérard M, Kleinschek M, Cua D, Di Santo JP, Eberl G.

Nat Immunol. 2011 Apr;12(4):320-6. doi: 10.1038/ni.2002. Epub 2011 Feb 20.

PMID:
21336274
12.

Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block.

Satoh-Takayama N.

Int Immunol. 2016 Jan;28(1):29-34. doi: 10.1093/intimm/dxv054. Epub 2015 Oct 13. Review.

PMID:
26462712
13.

The role of the novel Th17 cytokine IL-26 in intestinal inflammation.

Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, Diepolder HM, Auernhammer CJ, Brand S.

Gut. 2009 Sep;58(9):1207-17. doi: 10.1136/gut.2007.130112. Epub 2008 May 15.

PMID:
18483078
14.

IL-22-producing RORγt-dependent innate lymphoid cells play a novel protective role in murine acute hepatitis.

Matsumoto A, Kanai T, Mikami Y, Chu PS, Nakamoto N, Ebinuma H, Saito H, Sato T, Yagita H, Hibi T.

PLoS One. 2013 Apr 23;8(4):e62853. doi: 10.1371/journal.pone.0062853. Print 2013.

15.

Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.

Ogino T, Nishimura J, Barman S, Kayama H, Uematsu S, Okuzaki D, Osawa H, Haraguchi N, Uemura M, Hata T, Takemasa I, Mizushima T, Yamamoto H, Takeda K, Doki Y, Mori M.

Gastroenterology. 2013 Dec;145(6):1380-91.e1. doi: 10.1053/j.gastro.2013.08.049. Epub 2013 Aug 29.

PMID:
23993972
16.

Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin.

Dyring-Andersen B, Geisler C, Agerbeck C, Lauritsen JP, Gúdjonsdottir SD, Skov L, Bonefeld CM.

Br J Dermatol. 2014 Mar;170(3):609-16. doi: 10.1111/bjd.12658.

PMID:
24125475
17.

Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.

Sanders TJ, McCarthy NE, Giles EM, Davidson KL, Haltalli ML, Hazell S, Lindsay JO, Stagg AJ.

Gastroenterology. 2014 May;146(5):1278-88.e1-2. doi: 10.1053/j.gastro.2014.01.057. Epub 2014 Feb 4.

PMID:
24503130
18.

The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells.

Qiu J, Heller JJ, Guo X, Chen ZM, Fish K, Fu YX, Zhou L.

Immunity. 2012 Jan 27;36(1):92-104. doi: 10.1016/j.immuni.2011.11.011. Epub 2011 Dec 15.

19.

Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.

Liu C, Xia X, Wu W, Wu R, Tang M, Chen T, Xu F, Cong Y, Xu X, Liu Z.

Clin Exp Immunol. 2013 Jul;173(1):102-11. doi: 10.1111/cei.12084.

20.

Thy1+ Sca1+ innate lymphoid cells infiltrate the CNS during autoimmune inflammation, but do not contribute to disease development.

Mair F, Becher B.

Eur J Immunol. 2014 Jan;44(1):37-45. doi: 10.1002/eji.201343653. Epub 2013 Oct 7.

Supplemental Content

Support Center